Adalat
Adalat
- Adalat (nifedipine) is normally dispensed in pharmacies and through licensed online pharmacies; it is classified as a prescription-only medicine in most countries, though branded and generic products are widely available and in some markets or pharmacies it may be obtainable without a receipt or formal prescription.
- Adalat is used to treat hypertension and angina (including chronic stable and vasospastic angina). It is a dihydropyridine calcium channel blocker that inhibits L-type calcium channels in vascular smooth muscle, causing vasodilation and reduced peripheral vascular resistance and myocardial oxygen demand.
- Typical doses: for hypertension and chronic angina start with a nifedipine ER 30 mg once daily; maintenance commonly 60–90 mg once daily with a typical ER maximum of 90 mg/day; immediate‑release forms are lower (10–20 mg) and used less commonly for acute situations.
- Adalat is administered orally as extended‑release (ER/CR) tablets, modified‑release tablets, or immediate‑release capsules/tablets (film‑coated tablets in many markets); no parenteral formulation for outpatient use.
- Onset: immediate‑release nifedipine can begin to lower blood pressure within about 20–30 minutes; extended‑release formulations typically begin working within 1–2 hours.
- Duration: immediate‑release effects last roughly 4–6 hours; extended‑release nifedipine is formulated for once‑daily dosing and provides up to 24 hours of blood‑pressure control.
- Avoid or limit alcohol while taking Adalat, as alcohol can potentiate hypotension, dizziness and flushing; use caution with concurrent sedatives or other blood‑pressure lowering agents.
- The most common side effect is headache (other frequent effects include flushing, peripheral edema, dizziness/lightheadedness and fatigue).
- Would you like to try adalat without a prescription?
Basic Adalat Information
- INN (International Nonproprietary Name): Nifedipine.
- Brand Names Available In Canada (English): Adalat is the widely recognised brand name internationally; equivalent products and generics may be labelled as Adalat, Adalat CC, Procardia XL (US), Nifediac or local generic names depending on manufacturer and supply.
- ATC Code: C08CA05 — C08: Calcium Channel Blockers; C08CA: Dihydropyridine Derivatives; C08CA05: Nifedipine.
- Forms & Dosages: Extended-Release Tablets 30 mg, 60 mg, 90 mg; Immediate-Release Capsules 10 mg and 20 mg (less common, reserved for acute care); Modified-Release Tablets in several strengths.
- Manufacturers In Canada (English): Original brand manufacturer Bayer AG is the originator; common generic suppliers include Teva, Sandoz/Novartis, Mylan, Actavis and Apotex among others.
- Registration Status In Canada (English): Nifedipine products are marketed internationally and require national regulatory approval and a Drug Identification Number (DIN) for sale in Canada; availability depends on supplier and provincial formularies.
- OTC / Rx Classification: Prescription-only medicine (Rx) in most jurisdictions.
Everyday Use & Best Practices
Morning Vs Evening Dosing In Canadian Routines
Many Canadians ask whether to take Adalat in the morning or evening.
Extended-release Adalat (nifedipine ER) is designed for once-daily dosing at about the same time each day.
For most patients, morning dosing after breakfast and with a glass of water fits daily routines and provides daytime blood-pressure control.
Evening dosing can help reduce daytime flushing for people who work outdoors, shift workers, or anyone troubled by midday warmth or facial flushing.
Immediate-release nifedipine is intended for supervised, short-term in-hospital use and is not for unsupervised home use.
Start low and titrate exactly as directed by your prescriber; do not stop suddenly because abrupt withdrawal can worsen angina or blood pressure control.
When Health Canada issues product-specific advisories consult the Recalls and Safety Alerts page and keep your DIN and packaging for pharmacist review.
Taking With Or Without Meals (Canadian Diet Context)
Extended-release Adalat tablets (30, 60, 90 mg) are formulated to release nifedipine steadily and are less affected by food than immediate-release forms.
High-fat meals common in some Canadian breakfasts, such as a full breakfast or heavier weekend meals, can delay absorption of certain formulations but do not typically change the overall effect of ER tablets.
Avoid grapefruit juice because it inhibits CYP3A4 and can raise nifedipine blood levels, increasing side-effect risk.
Prefer taking your dose at the same point in your routine — for example, after brushing teeth or finishing breakfast — to reduce missed doses.
| Formulation | Typical Effect On Absorption |
|---|---|
| Extended-Release Tablets (ER 30/60/90 mg) | Designed for steady release; minimal peak-related effects; consistent with meals |
| Immediate-Release Capsules (10/20 mg) | Faster absorption; peak effects may be affected by fatty meals; intended for short-term supervised use |
- Home Dosing Checklist: Take at same time daily; use a pill organiser; keep medicine in original labelled packaging; record any dizziness, swelling or chest symptoms; bring DIN to pharmacist.
Safety Priorities
Who Should Avoid It (Health Canada Advisories)
Adalat (nifedipine) is prescription-only and has important absolute contraindications.
- Do not use if you have known hypersensitivity to nifedipine or tablet excipients.
- Avoid in severe aortic stenosis and cardiogenic shock.
- Recent myocardial infarction within the last two weeks is a contraindication to nifedipine initiation for outpatient use.
- Exercise caution with significant hepatic impairment; nifedipine is metabolized in the liver and dose reductions may be needed.
- Concurrent rifampin use is contraindicated because it is a strong CYP3A4 inducer and reduces nifedipine efficacy.
Activities To Limit (Driving, Workplace Safety)
Common side effects that affect safety include dizziness, lightheadedness and flushing.
Start with caution when driving, operating heavy machinery or working at height until you know how Adalat affects you.
Outdoor workers in cold climates should consider that increased peripheral vasodilation may worsen heat loss or swelling; protective clothing and hydration are prudent.
- Do not drive if you feel dizzy, lightheaded or faint after taking a dose.
- Avoid heavy machinery until you are sure side effects are absent or manageable.
- Inform your employer or occupational health nurse if you have recurring dizziness while on therapy.
Dosage & Adjustments
General Regimen (DIN References)
Usual outpatient starting dose for hypertension or chronic stable angina is one 30 mg extended-release tablet once daily.
Titrate as directed by your prescriber to 60–90 mg once daily if needed; a common maximum ER dose is 90 mg per day.
Immediate-release forms (10–20 mg) exist but are less common for outpatient management and are usually reserved for acute care.
When filling a prescription in Canada, ask your pharmacist to confirm the product DIN and the exact strength on the label to assist with provincial drug-plan claims.
| Use | Starting Dose | Maintenance | Max ER Dose |
|---|---|---|---|
| Hypertension | 30 mg ER Once Daily | 60–90 mg Once Daily | 90 mg/day |
| Chronic Stable Angina | 30 mg ER Once Daily | Up To 90 mg Once Daily | 90 mg/day |
Special Cases (Elderly, Comorbidities)
Elderly patients frequently require lower starting doses and slower titration because of increased hypotension risk.
In hepatic impairment reduce dose and monitor liver function tests since nifedipine undergoes hepatic metabolism.
Kidney impairment typically does not require major dose changes, but monitor blood pressure and renal function because poorly controlled hypertension can affect kidneys.
- Monitoring Checklist: BP reading within 1–2 weeks of start or dose change, review symptoms (dizziness, swelling), periodic LFTs if hepatic disease present, keep medication list updated.
User Testimonials
Positive Reports From Canadian Patients
Many Canadian patients report improved blood-pressure control and fewer angina episodes with extended-release nifedipine (Adalat ER 30–90 mg).
Once-daily dosing is a common positive: patients use weekly pill organisers from community pharmacies like Shoppers Drug Mart or London Drugs to simplify adherence.
Travellers appreciate bringing original packaging with the DIN when crossing provincial lines for continuity of care.
Common Challenges In Forums (Reddit Canada, Health Boards)
Forum discussions often mention peripheral ankle swelling, headaches and transient flushing as the most frequent practical complaints.
Rural patients report reliance on community pharmacists for dose reviews and may face longer waits for specialist appointments.
Cross-border shoppers note different brand names such as Procardia XL in the US and differences in cost and packaging.
- Pros: Once-daily convenience, effective BP reduction, better angina control for many.
- Cons: Peripheral oedema, headaches, possible dizziness during titration, cost variations across brands.
- What To Tell Your Pharmacist Checklist: current symptoms, all prescription and OTC meds, use of grapefruit juice or herbal supplements, travel plans and provincial health card details.
Buying Guide
Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)
Adalat and nifedipine ER products are prescription-only in most sources, and are stocked by major Canadian pharmacy chains and independent pharmacies.
Ask the dispensing pharmacist to confirm the DIN on the pill bottle or package so you know the exact product dispensed.
Many pharmacies dispense generic nifedipine ER made by Teva, Sandoz or Apotex.
In our online pharmacy, adalat is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Price Comparison (In-Store Vs Online, Cross-Border Notes)
Generic nifedipine ER products are generally less expensive than branded Adalat.
Online Canadian pharmacies can offer competitive pricing but ensure they require a valid prescription and are Canadian-licensed.
Cross-border purchases may show US brand names such as Procardia XL; differences in formulation labelling and regulatory status should be checked with a pharmacist.
| Where To Buy | Notes |
|---|---|
| Shoppers Drug Mart / Rexall / London Drugs / Jean Coutu | Major chains; can confirm DIN and formulary coverage |
| Independent Pharmacies | Often provide counselling and help with prior authorizations |
| Online Canadian Pharmacies | Require prescription; watch for licensing and delivery times |
- Bring To The Pharmacy: prescription, provincial health card, any current medication list, and note the DIN if available.
What’s Inside & How It Works
Ingredients Overview
The active ingredient in Adalat is nifedipine, a dihydropyridine calcium channel blocker.
Extended-release tablets contain nifedipine plus manufacturer-specific excipients that control the release rate; inactive ingredients vary by manufacturer and are listed on the product monograph.
If you have allergies or intolerances to excipients such as lactose or certain dyes, check the specific manufacturer leaflet or ask your pharmacist to confirm.
Mechanism Basics
Nifedipine inhibits L-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral vascular resistance.
Lower peripheral resistance reduces blood pressure and myocardial oxygen demand, making nifedipine useful for hypertension and angina.
ER formulations provide steadier plasma levels and avoid high peaks that can cause reflex tachycardia.
| Feature | ER Nifedipine | Immediate-Release |
|---|---|---|
| Plasma Levels | Steady over 24 hours | Rapid peaks, shorter duration |
| Risk Of Reflex Tachycardia | Lower | Higher |
Main Indications
Approved Uses In Canada
Nifedipine is indicated for the management of hypertension and angina pectoris, including chronic stable and vasospastic angina.
Health Canada product monographs and the DIN on your medication will list approved indications for the specific product you receive.
Off-Label Uses By Canadian Physicians
Specialists may use nifedipine off-label in select paediatric settings, such as post-transplant hypertension, with weight-based dosing and specialist oversight.
Immediate-release nifedipine has historically seen acute use in hospitals but is not recommended for unsupervised home use due to the risk of rapid blood-pressure drops.
| Use | Typical Dosing |
|---|---|
| Hypertension | 30 mg ER once daily; titrate to 60–90 mg as needed |
| Chronic Stable Angina | 30 mg ER once daily; up to 90 mg if required |
| Pediatric (Off-Label) | 0.25–0.5 mg/kg/day divided; specialist-managed |
Interaction Warnings
Food Interactions (Alcohol, Caffeine)
Avoid grapefruit juice while taking nifedipine because it inhibits CYP3A4 and can lead to elevated nifedipine blood concentrations and more side effects.
Alcohol and caffeinated energy drinks may intensify dizziness or tachycardia, particularly during dose titration, so moderate intake is advised.
Consider regional dietary habits and counsel accordingly during pharmacy counselling.
Drug Conflicts (Health Canada Database)
High-risk drug interactions include strong CYP3A4 inducers like rifampin, which can reduce nifedipine concentrations and treatment effect.
Certain antifungals and macrolide antibiotics can inhibit CYP3A4 and increase nifedipine exposure; concurrent use requires monitoring or adjustment.
Combining nifedipine with other vasodilators, nitrates or certain antihypertensives can cause symptomatic hypotension.
| Avoid | Use With Caution |
|---|---|
| Rifampin (reduces nifedipine effect) | Certain macrolides and azole antifungals (may raise nifedipine levels) |
| Grapefruit juice | Concurrent strong vasodilators and multiple antihypertensives |
- Always have your pharmacist run an interaction check at each refill and when adding new medications, including herbal remedies such as St. John’s wort.
Latest Evidence & Insights
Highlight Canadian And International Research
Nifedipine has long-standing evidence for effectiveness in blood-pressure control and angina prophylaxis since its approvals in the 1980s.
Extended-release formulations reduce peak-related adverse effects seen with immediate-release products.
Canadian observational data highlight peripheral oedema and hypotension risk in older adults and recommend vigilance during titration.
| Study Type | Key Outcome | Practice Insight |
|---|---|---|
| Randomised Controlled Trials | Effective BP reduction versus placebo | ER formulations improve tolerability |
| Meta-Analyses | Class efficacy comparable to other dihydropyridines | Amlodipine may be preferable in frail elderly for smoother hemodynamics |
| Canadian Cohorts | Higher incidence of ankle oedema in older patients | Monitor and consider dose adjustments or alternate agents |
Health Canada product monographs remain the regulatory reference for approved indications and safety advisories.
Alternative Choices
Comparable Medicines (Pros/Cons Checklist)
Alternatives in the calcium channel blocker class include amlodipine, felodipine and nicardipine.
- Amlodipine: longer half-life, once-daily dosing with potentially less reflex tachycardia; commonly used as first-line CCB.
- Felodipine: similar efficacy; formulation availability varies by market.
- Nicardipine: IV formulations available and used in acute care settings.
Switching Considerations
Switch decisions should consider comorbidities such as heart failure or diabetes, side-effect profiles like ankle oedema, cost and provincial formulary coverage.
Tapering and precise switch instructions belong to the prescriber; pharmacists can support adherence, DIN confirmation and patient counselling.
| Feature | Adalat ER (Nifedipine) | Amlodipine |
|---|---|---|
| Dosing Frequency | Once Daily (ER) | Once Daily |
| Onset | Faster vasodilation than amlodipine initially | Slower onset, longer half-life |
| Common AEs | Flushing, peripheral oedema, headache | Peripheral oedema, less reflex tachycardia |
Regulation Snapshot
Health Canada Approval And DIN Requirements
Nifedipine products must be approved for marketing in Canada and carry a Drug Identification Number (DIN).
Confirm the DIN on the dispensed package when you pick up Adalat so pharmacists can verify the exact product for counselling and claims.
Provincial Coverage & Reimbursement (ODB, PharmaCare, RAMQ)
Coverage varies by province and by public programs such as Ontario Drug Benefit (ODB), BC PharmaCare and RAMQ in Quebec.
Pharmacists can assist with Special Authority or prior-authorisation requests when a particular formulation or brand is required by a formulary.
| Province/Plan | Typical Pathway |
|---|---|
| Ontario (ODB) | Formulary listing or Special Authority via pharmacist or prescriber |
| British Columbia (PharmaCare) | Eligibility and Plan-specific coverage; check with pharmacist |
| Quebec (RAMQ) | Provincial formulary and potential prior authorizations |
FAQ
Can I Drive After Starting Adalat?
Start with caution when driving after your first dose or after a dose increase.
Avoid driving if you experience dizziness, lightheadedness or faintness after taking Adalat.
Report persistent side effects to your prescriber or pharmacist before returning to driving duties.
What If I Miss A Dose Or Run Out While Travelling Across Provinces?
If you miss a dose, take it as soon as you remember unless it is close to the next scheduled dose; do not double the dose.
When travelling keep medication in original labelled packaging with the DIN and prescriber contact information.
If you run out while travelling, visit a local pharmacy with your prescription or contact your prescriber; pharmacies across provinces can often transfer or refill prescriptions when documentation is provided.
Can I Take Herbal Remedies While On Adalat?
Discuss herbal remedies with your pharmacist; grapefruit juice is contraindicated and St. John's wort may interact via CYP enzymes.
- Travel Checklist: original prescription label, DIN, provincial health card, and at least a week’s extra supply when possible.
Guidelines For Proper Use
Canadian Pharmacist And Provincial Health Authority Recommendations
Follow prescriber directions and verify DIN and manufacturer information with your pharmacist at each dispense.
Community pharmacists routinely advise baseline blood-pressure and heart-rate checks prior to starting therapy and review potential interactions and contraindications.
Enroll in provincial drug plans if eligible and use pharmacist counselling for adherence tools like blister packs or weekly organisers.
Monitoring Schedule & When To Call 911
Recommended monitoring includes a blood-pressure check within 1–2 weeks after initiation or dose change, then periodic reviews as clinically indicated.
Monitor for peripheral oedema, dizziness, syncope, worsening chest pain or signs of liver dysfunction.
| When To Call 911 | When To See Your Pharmacist/Doctor |
|---|---|
| Severe hypotension with fainting, severe dizziness, or collapse | New or worsening peripheral oedema, ongoing dizziness, or suspected side effects |
| Severe allergic reaction: swelling of face or difficulty breathing | Concerns about interactions, running out of medication, or planning a medication switch |
- Printable One-Page Checklist: baseline BP, date of first dose, follow-up BP at 1–2 weeks, report symptoms to pharmacist.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Victoria | British Columbia | 5-7 days |
| Hamilton | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
Final Notes
Adalat’s active ingredient is nifedipine (ATC C08CA05), a dihydropyridine calcium channel blocker indicated for hypertension and angina.
Keep medication in original labelled packaging with the DIN when travelling or when asking your pharmacist for help.
Do not stop Adalat abruptly; consult your prescriber for a tapering plan to avoid worsening angina or uncontrolled blood pressure.
If in doubt about interactions, contraindications or dosing for special populations such as children or those with liver disease, consult your pharmacist or prescriber before making changes.